{"transactions":[{"id":2521802,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-11-08T22:23:08.000Z","date":"2021-11-08","kind":"exercise","acquired":false,"shares":4166,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":5.46,"exercise_date":"2012-06-22","expiration_date":"2022-05-22","underlying":"Common Stock","underlying_shares":4166},"source":{"system":"sec-edgar","filing":"0001061983-21-000253","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000253/edgardoc.xml","form_type":"4"}},{"id":2521801,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-11-08T22:23:08.000Z","date":"2021-11-08","kind":"exercise","acquired":false,"shares":22302,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":4.02,"exercise_date":"2013-02-02","expiration_date":"2023-01-02","underlying":"Common Stock","underlying_shares":22302},"source":{"system":"sec-edgar","filing":"0001061983-21-000253","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000253/edgardoc.xml","form_type":"4"}},{"id":2521800,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-08T22:23:08.000Z","date":"2021-11-08","kind":"sale","acquired":false,"shares":4166,"price":41.3338,"value":172196.6108,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount includes 3,128 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":28932,"source":{"system":"sec-edgar","filing":"0001061983-21-000253","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000253/edgardoc.xml","form_type":"4"}},{"id":2521799,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-08T22:23:08.000Z","date":"2021-11-08","kind":"exercise","acquired":true,"shares":4166,"price":5.46,"value":22746.36,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount includes 3,128 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":33098,"source":{"system":"sec-edgar","filing":"0001061983-21-000253","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000253/edgardoc.xml","form_type":"4"}},{"id":2521798,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-08T22:23:08.000Z","date":"2021-11-08","kind":"sale","acquired":false,"shares":22302,"price":41.3338,"value":921826.4076,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount includes 3,128 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":28932,"source":{"system":"sec-edgar","filing":"0001061983-21-000253","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000253/edgardoc.xml","form_type":"4"}},{"id":2521797,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-08T22:23:08.000Z","date":"2021-11-08","kind":"exercise","acquired":true,"shares":22302,"price":4.02,"value":89654.04,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount includes 3,128 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":51234,"source":{"system":"sec-edgar","filing":"0001061983-21-000253","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000253/edgardoc.xml","form_type":"4"}},{"id":2552744,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-04T23:02:08.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":510,"price":36.74,"value":18737.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.  Shares are full vested from the moment of grant.  Shares issued at per share price of $36.74, representing the Issuer's closing stock price on October 1, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 3,128 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":28932,"source":{"system":"sec-edgar","filing":"0001061983-21-000228","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000228/edgardoc.xml","form_type":"4"}},{"id":2645665,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T20:45:21.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":893,"price":20.98,"value":18735.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.  Shares are full vested from the moment of grant.  Shares issued at per share price of $20.98, representing the Issuer's closing stock price on July 1, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 2,618 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":28422,"source":{"system":"sec-edgar","filing":"0001061983-21-000173","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000173/edgardoc.xml","form_type":"4"}},{"id":2714985,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-05-14T00:01:56.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options shall vest and become exercisable in 12 equal monthly installments, the first such installment vesting on 06/12/2021 and the last such installment vesting on 05/12/2022."}],"balance_after":10000,"derivative":{"exercise_price":24.32,"exercise_date":"2021-06-12","expiration_date":"2031-05-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001061983-21-000139","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000139/edgardoc.xml","form_type":"4"}},{"id":2714984,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-14T00:01:56.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Comprised of restricted stock units that will vest in full and in one installment on 05/12/2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 1,725 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":27529,"source":{"system":"sec-edgar","filing":"0001061983-21-000139","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000139/edgardoc.xml","form_type":"4"}},{"id":2758705,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-05T21:47:14.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":767,"price":24.44,"value":18745.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.  Shares are full vested from the moment of grant.  Shares issued at per share price of $24.44, representing the Issuer's closing stock price on April 1, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 1,725 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":22529,"source":{"system":"sec-edgar","filing":"0001061983-21-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000097/edgardoc.xml","form_type":"4"}},{"id":2777953,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-03-19T22:55:29.000Z","date":"2021-03-19","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":5.88,"exercise_date":"2012-02-03","expiration_date":"2022-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001061983-21-000085","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000085/edgardoc.xml","form_type":"4"}},{"id":2777952,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-19T22:55:29.000Z","date":"2021-03-19","kind":"sale","acquired":false,"shares":10000,"price":24.4468,"value":244468.0,"ownership":{"direct":true},"balance_after":21762,"source":{"system":"sec-edgar","filing":"0001061983-21-000085","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000085/edgardoc.xml","form_type":"4"}},{"id":2777951,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-19T22:55:29.000Z","date":"2021-03-19","kind":"exercise","acquired":true,"shares":10000,"price":5.88,"value":58800.0,"ownership":{"direct":true},"balance_after":31762,"source":{"system":"sec-edgar","filing":"0001061983-21-000085","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000085/edgardoc.xml","form_type":"4"}},{"id":2792780,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-03-12T23:58:10.000Z","date":"2021-03-12","kind":"exercise","acquired":false,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":8.64,"exercise_date":"2011-06-18","expiration_date":"2021-05-18","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001061983-21-000083","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000083/edgardoc.xml","form_type":"4"}},{"id":2792779,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-03-12T23:58:10.000Z","date":"2021-03-12","kind":"exercise","acquired":false,"shares":7006,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":5.88,"exercise_date":"2012-02-03","expiration_date":"2022-01-03","underlying":"Common Stock","underlying_shares":7006},"source":{"system":"sec-edgar","filing":"0001061983-21-000083","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000083/edgardoc.xml","form_type":"4"}},{"id":2792778,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-12T23:58:10.000Z","date":"2021-03-12","kind":"sale","acquired":false,"shares":3333,"price":21.2179,"value":70719.2607,"ownership":{"direct":true},"balance_after":21762,"source":{"system":"sec-edgar","filing":"0001061983-21-000083","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000083/edgardoc.xml","form_type":"4"}},{"id":2792777,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-12T23:58:10.000Z","date":"2021-03-12","kind":"exercise","acquired":true,"shares":3333,"price":8.64,"value":28797.12,"ownership":{"direct":true},"balance_after":25095,"source":{"system":"sec-edgar","filing":"0001061983-21-000083","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000083/edgardoc.xml","form_type":"4"}},{"id":2792776,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-12T23:58:10.000Z","date":"2021-03-12","kind":"sale","acquired":false,"shares":7006,"price":21.2179,"value":148652.6074,"ownership":{"direct":true},"balance_after":21762,"source":{"system":"sec-edgar","filing":"0001061983-21-000083","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000083/edgardoc.xml","form_type":"4"}},{"id":2792775,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-12T23:58:10.000Z","date":"2021-03-12","kind":"exercise","acquired":true,"shares":7006,"price":5.88,"value":41195.28,"ownership":{"direct":true},"balance_after":28768,"source":{"system":"sec-edgar","filing":"0001061983-21-000083","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000083/edgardoc.xml","form_type":"4"}},{"id":2922126,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T23:17:00.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":958,"price":19.56,"value":18738.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.  Shares are full vested from the moment of grant.  Shares issued at per share price of $19.56, representing the Issuer's closing stock price on January 4, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 958 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":21762,"source":{"system":"sec-edgar","filing":"0001061983-21-000013","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000013/edgardoc.xml","form_type":"4"}},{"id":2945049,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-12-15T23:09:01.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"shares":7716,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":12.96,"exercise_date":"2011-02-03","expiration_date":"2021-01-03","underlying":"Common Stock","underlying_shares":7716},"source":{"system":"sec-edgar","filing":"0001061983-20-000187","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000187/edgardoc.xml","form_type":"4"}},{"id":2945048,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-15T23:09:01.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":7716,"price":21.0003,"value":162038.3148,"ownership":{"direct":true},"balance_after":20804,"source":{"system":"sec-edgar","filing":"0001061983-20-000187","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000187/edgardoc.xml","form_type":"4"}},{"id":2945047,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-15T23:09:01.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":7716,"price":12.96,"value":99999.36,"ownership":{"direct":true},"balance_after":28520,"source":{"system":"sec-edgar","filing":"0001061983-20-000187","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000187/edgardoc.xml","form_type":"4"}},{"id":3073900,"issuer":{"id":147285,"kind":"organization","name":"TETRAPHASE PHARMACEUTICALS INC","symbol":"TTPH"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-29T16:14:23.000Z","date":"2020-07-28","kind":"other","acquired":false,"shares":191,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of that certain Agreement and Plan of Merger, dated as of June 24, 2020, by and among Tetraphase Pharmaceuticals, Inc., TTP Merger Sub, Inc. and La Jolla Pharmaceutical Company (the \"Merger Agreement\"), these shares were tendered and disposed of at the Acceptance Time (all terms capitalized but not defined shall have the meaning given to them in the Merger Agreement) in exchange for the right to receive (i) $2.00 per Share (the \"Cash Consideration\"), to the holder in cash, without interest and less any applicable withholding taxes, plus (ii) one non-transferable contractual contingent value right per Share (a \"CVR\") representing the right to receive certain consideration based on the achievement of net sales milestones."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-020623","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196903/000089924320020623/doc4.xml","form_type":"4"}},{"id":3073899,"issuer":{"id":147285,"kind":"organization","name":"TETRAPHASE PHARMACEUTICALS INC","symbol":"TTPH"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-29T16:14:23.000Z","date":"2020-07-28","kind":"other","acquired":false,"shares":1944,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of that certain Agreement and Plan of Merger, dated as of June 24, 2020, by and among Tetraphase Pharmaceuticals, Inc., TTP Merger Sub, Inc. and La Jolla Pharmaceutical Company (the \"Merger Agreement\"), these shares were tendered and disposed of at the Acceptance Time (all terms capitalized but not defined shall have the meaning given to them in the Merger Agreement) in exchange for the right to receive (i) $2.00 per Share (the \"Cash Consideration\"), to the holder in cash, without interest and less any applicable withholding taxes, plus (ii) one non-transferable contractual contingent value right per Share (a \"CVR\") representing the right to receive certain consideration based on the achievement of net sales milestones."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-020623","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196903/000089924320020623/doc4.xml","form_type":"4"}},{"id":3141264,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-05-20T21:04:24.000Z","date":"2020-05-18","kind":"exercise","acquired":false,"shares":3333,"price":22.22,"value":74059.26,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":16.86,"exercise_date":"2010-06-20","expiration_date":"2020-05-20","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001061983-20-000099","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000099/edgardoc.xml","form_type":"4"}},{"id":3141263,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T21:04:24.000Z","date":"2020-05-18","kind":"tax_withholding","acquired":false,"shares":2529,"price":22.22,"value":56194.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a \"net exercise\" of an outstanding stock option. The Reporting Person received 804 shares of Common Stock on the net exercise of a stock option to purchase 3,333 shares of Common Stock. The Issuer withheld 2,529 shares of Common Stock underlying the stock option for payment of the exercise price using a stock price on May 18, 2020 of $22.22."}],"balance_after":20804,"source":{"system":"sec-edgar","filing":"0001061983-20-000099","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000099/edgardoc.xml","form_type":"4"}},{"id":3141262,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T21:04:24.000Z","date":"2020-05-18","kind":"exercise","acquired":true,"shares":3333,"price":16.86,"value":56194.38,"ownership":{"direct":true},"balance_after":23333,"source":{"system":"sec-edgar","filing":"0001061983-20-000099","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000099/edgardoc.xml","form_type":"4"}},{"id":3149422,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-05-14T20:45:33.000Z","date":"2020-05-13","kind":"grant","acquired":true,"shares":20000,"price":21.61,"value":432200.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest and become exercisable in 12 equal monthly installments as from the date of the grant."}],"balance_after":20000,"derivative":{"exercise_price":21.61,"expiration_date":"2030-05-13","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001061983-20-000088","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000088/edgardoc.xml","form_type":"4"}},{"id":3199692,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-20T19:21:42.000Z","date":"2020-03-06","kind":"sale","acquired":false,"shares":8000,"price":14.824,"value":118592.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001061983-20-000069","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000069/edgardoc.xml","form_type":"4"}},{"id":3199691,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-20T19:21:26.000Z","date":"2019-05-22","kind":"gift","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Bona Fide Gift"}],"balance_after":28000,"source":{"system":"sec-edgar","filing":"0001061983-20-000068","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000068/edgardoc.xml","form_type":"5"}},{"id":3493872,"issuer":{"id":147285,"kind":"organization","name":"TETRAPHASE PHARMACEUTICALS INC","symbol":"TTPH"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-06-11T19:19:45.000Z","date":"2019-06-10","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in equal quarterly installments over a one-year period measured from the date of grant."}],"balance_after":16500,"derivative":{"exercise_price":0.77,"expiration_date":"2029-06-09","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-19-036259","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196903/000120919119036259/doc4.xml","form_type":"4"}},{"id":3521846,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-05-17T21:07:34.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":20000,"price":10.68,"value":213600.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 15, 2020"}],"balance_after":20000,"derivative":{"exercise_price":10.68,"expiration_date":"2029-05-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001061983-19-000035","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198319000035/edgardoc.xml","form_type":"4"}},{"id":3910465,"issuer":{"id":147285,"kind":"organization","name":"TETRAPHASE PHARMACEUTICALS INC","symbol":"TTPH"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-06-01T16:15:47.000Z","date":"2018-05-30","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in equal quarterly installments over a one-year period measured from the date of grant."}],"balance_after":12500,"derivative":{"exercise_price":3.68,"expiration_date":"2028-05-29","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-18-034658","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196903/000120919118034658/doc4.xml","form_type":"4"}},{"id":3928855,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-05-17T22:28:14.000Z","date":"2018-05-16","kind":"grant","acquired":true,"shares":20000,"price":9.45,"value":189000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 16, 2019"}],"balance_after":20000,"derivative":{"exercise_price":9.45,"expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001061983-18-000026","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000026/edgardoc.xml","form_type":"4"}},{"id":4108351,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-01-04T23:35:16.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":21428,"price":3.5002,"value":75002.2856,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was issued to the reporting person pursuant to the Cytokinetics 2004 Equity Incentive Plan in lieu of an annual retainer of $75,000.00."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable as to 21,428 shares divided into equal monthly installments such that the option shall be 100% vested on January 2, 2019."}],"balance_after":21428,"derivative":{"exercise_price":8.75,"exercise_date":"2018-02-02","expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":21428},"source":{"system":"sec-edgar","filing":"0001061983-18-000001","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000001/edgardoc.xml","form_type":"4"}},{"id":4144025,"issuer":{"id":147285,"kind":"organization","name":"TETRAPHASE PHARMACEUTICALS INC","symbol":"TTPH"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-04T09:02:10.000Z","date":"2017-11-29","kind":"purchase","acquired":true,"shares":3880,"price":6.45,"value":25026.0,"ownership":{"direct":true},"balance_after":38880,"source":{"system":"sec-edgar","filing":"0001209191-17-063360","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196903/000120919117063360/doc4.xml","form_type":"4"}},{"id":4192480,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-10-04T22:53:52.000Z","date":"2017-10-02","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22302,"derivative":{"exercise_price":4.02,"exercise_date":"2013-02-02","expiration_date":"2023-01-02","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001061983-17-000059","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000059/edgardoc.xml","form_type":"4"}},{"id":4192479,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-04T22:53:52.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":400,"price":14.675,"value":5870.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2017."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001061983-17-000059","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000059/edgardoc.xml","form_type":"4"}},{"id":4192478,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-04T22:53:52.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":2490,"price":14.65,"value":36478.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2017."}],"balance_after":30400,"source":{"system":"sec-edgar","filing":"0001061983-17-000059","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000059/edgardoc.xml","form_type":"4"}},{"id":4192477,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-04T22:53:52.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":300,"price":14.6,"value":4380.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2017."}],"balance_after":32890,"source":{"system":"sec-edgar","filing":"0001061983-17-000059","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000059/edgardoc.xml","form_type":"4"}},{"id":4192476,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-04T22:53:52.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":810,"price":14.55,"value":11785.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2017."}],"balance_after":33190,"source":{"system":"sec-edgar","filing":"0001061983-17-000059","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000059/edgardoc.xml","form_type":"4"}},{"id":4192475,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-04T22:53:52.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":600,"price":14.45,"value":8670.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2017."}],"balance_after":34000,"source":{"system":"sec-edgar","filing":"0001061983-17-000059","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000059/edgardoc.xml","form_type":"4"}},{"id":4192474,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-04T22:53:52.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":400,"price":14.4,"value":5760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2017."}],"balance_after":34600,"source":{"system":"sec-edgar","filing":"0001061983-17-000059","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000059/edgardoc.xml","form_type":"4"}},{"id":4192473,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-04T22:53:52.000Z","date":"2017-10-02","kind":"exercise","acquired":true,"shares":5000,"price":4.02,"value":20100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise(s) reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2017."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001061983-17-000059","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000059/edgardoc.xml","form_type":"4"}},{"id":4219939,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-09-01T23:21:34.000Z","date":"2017-09-01","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27302,"derivative":{"exercise_price":4.02,"exercise_date":"2013-02-02","expiration_date":"2023-01-02","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001061983-17-000055","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000055/edgardoc.xml","form_type":"4"}},{"id":4219938,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-01T23:21:34.000Z","date":"2017-09-01","kind":"sale","acquired":false,"shares":400,"price":14.9,"value":5960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2017."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001061983-17-000055","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000055/edgardoc.xml","form_type":"4"}},{"id":4219937,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-01T23:21:34.000Z","date":"2017-09-01","kind":"sale","acquired":false,"shares":700,"price":14.85,"value":10395.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2017."}],"balance_after":30400,"source":{"system":"sec-edgar","filing":"0001061983-17-000055","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000055/edgardoc.xml","form_type":"4"}},{"id":4219936,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-01T23:21:34.000Z","date":"2017-09-01","kind":"sale","acquired":false,"shares":500,"price":14.75,"value":7375.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2017."}],"balance_after":31100,"source":{"system":"sec-edgar","filing":"0001061983-17-000055","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000055/edgardoc.xml","form_type":"4"}},{"id":4219935,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-01T23:21:34.000Z","date":"2017-09-01","kind":"sale","acquired":false,"shares":500,"price":14.725,"value":7362.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2017."}],"balance_after":31600,"source":{"system":"sec-edgar","filing":"0001061983-17-000055","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000055/edgardoc.xml","form_type":"4"}},{"id":4219934,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-01T23:21:34.000Z","date":"2017-09-01","kind":"sale","acquired":false,"shares":900,"price":14.7,"value":13230.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2017."}],"balance_after":32100,"source":{"system":"sec-edgar","filing":"0001061983-17-000055","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000055/edgardoc.xml","form_type":"4"}},{"id":4219933,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-01T23:21:34.000Z","date":"2017-09-01","kind":"sale","acquired":false,"shares":600,"price":14.675,"value":8805.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2017."}],"balance_after":33000,"source":{"system":"sec-edgar","filing":"0001061983-17-000055","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000055/edgardoc.xml","form_type":"4"}},{"id":4219932,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-01T23:21:34.000Z","date":"2017-09-01","kind":"sale","acquired":false,"shares":1100,"price":14.65,"value":16115.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2017."}],"balance_after":33600,"source":{"system":"sec-edgar","filing":"0001061983-17-000055","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000055/edgardoc.xml","form_type":"4"}},{"id":4219931,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-01T23:21:34.000Z","date":"2017-09-01","kind":"sale","acquired":false,"shares":300,"price":14.6,"value":4380.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2017."}],"balance_after":34700,"source":{"system":"sec-edgar","filing":"0001061983-17-000055","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000055/edgardoc.xml","form_type":"4"}},{"id":4219930,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-01T23:21:34.000Z","date":"2017-09-01","kind":"exercise","acquired":true,"shares":5000,"price":4.02,"value":20100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise(s) reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2017."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001061983-17-000055","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000055/edgardoc.xml","form_type":"4"}},{"id":4221851,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-08-30T23:29:45.000Z","date":"2017-08-29","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":32302,"derivative":{"exercise_price":4.02,"exercise_date":"2013-02-02","expiration_date":"2023-01-02","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001061983-17-000050","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000050/edgardoc.xml","form_type":"4"}},{"id":4221850,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-30T23:29:45.000Z","date":"2017-08-29","kind":"sale","acquired":false,"shares":5000,"price":14,"value":70000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2017."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001061983-17-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000050/edgardoc.xml","form_type":"4"}},{"id":4221849,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-30T23:29:45.000Z","date":"2017-08-29","kind":"exercise","acquired":true,"shares":5000,"price":4.02,"value":20100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise(s) reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2017."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001061983-17-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000050/edgardoc.xml","form_type":"4"}},{"id":4297834,"issuer":{"id":147285,"kind":"organization","name":"TETRAPHASE PHARMACEUTICALS INC","symbol":"TTPH"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2017-06-01T17:02:37.000Z","date":"2017-05-31","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in equal quarterly installments over a one-year period measured from the date of grant."}],"balance_after":12500,"derivative":{"exercise_price":6.89,"expiration_date":"2027-05-30","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-17-036841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196903/000120919117036841/doc4.xml","form_type":"4"}},{"id":4310417,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-05-22T21:56:14.000Z","date":"2017-05-18","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 18, 2018."}],"balance_after":20000,"derivative":{"exercise_price":14.25,"exercise_date":"2017-06-18","expiration_date":"2027-05-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001061983-17-000030","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000030/edgardoc.xml","form_type":"4"}},{"id":4382151,"issuer":{"id":147285,"kind":"organization","name":"TETRAPHASE PHARMACEUTICALS INC","symbol":"TTPH"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-16T16:22:12.000Z","date":"2017-03-15","kind":"purchase","acquired":true,"shares":1000,"price":7.47,"value":7470.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":3825,"source":{"system":"sec-edgar","filing":"0001209191-17-021089","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196903/000120919117021089/doc4.xml","form_type":"4"}},{"id":4382150,"issuer":{"id":147285,"kind":"organization","name":"TETRAPHASE PHARMACEUTICALS INC","symbol":"TTPH"},"owners":[{"id":133764,"kind":"person","name":"GAGE L PATRICK","position":1,"cik":"0001196903","reported_name":"GAGE L PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-16T16:22:12.000Z","date":"2017-03-15","kind":"purchase","acquired":true,"shares":10000,"price":7.49,"value":74900.0,"ownership":{"direct":true},"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001209191-17-021089","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196903/000120919117021089/doc4.xml","form_type":"4"}}]}